Company: PHAT
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000950170-25-104548
Chunk: 1

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
, 2025 and December 31, 2024; no shares issued and outstanding at June 30, 2025 and December 31, 2024

     —

     —

     Common stock, $0.0001 par value; authorized shares — 400,000,000 at June 30, 2025 and December 31, 2024; issued and outstanding shares — 70,104,419 and 68,518,238 at June 30, 2025 and December 31, 2024, respectively

     6

     6

     Treasury stock — 19 shares at June 30, 2025 and December 31, 2024

     —

     —

     Additional paid-in capital

     1,027,297

     1,009,425

     Accumulated deficit

     (1,433,137
     )

     (1,263,011
     )

     Total stockholders’ deficit

     (405,834
     )

     (253,580
     )

     Total liabilities and stockholders’ deficit
      
     $
     250,220

     $
     378,318

See accompanying notes.